Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

TradingView
tradingview.com > news > urn:summary_document_transcript:quartr.com:3533969:0-absi-abs-201-advances-in-phase-ii-trials-targeting-major-unmet-needs-in-hair-loss-and-endometriosis

ABSI: ABS-201 advances in phase II trials, targeting major unmet needs in hair loss and endometriosis

3+ mon, 3+ day ago   (84+ words) TradingView ABSI: ABS-201 advances in phase II trials, targeting major unmet needs in hair loss and endometriosis AI-driven drug design has enabled rapid, cost-effective development of ABS-201, now in phase II trials for androgenic alopecia and soon for endometriosis. Preclinical…...

GeneOnline News
geneonline.com > alopecia-areata-market-shifts-toward-biologics-as-alternative-to-jak-inhibitors

Alopecia Areata Market Shifts Toward Biologics as Alternative to JAK Inhibitors

3+ mon, 4+ day ago   (163+ words) geneonline.com Alopecia Areata Market Shifts Toward Biologics as Alternative to JAK Inhibitors The market for alopecia areata treatments anticipates steady growth as rising patient awareness and an increased focus on aesthetic self-image drive demand for new therapeutic options. While…...

PharmiWeb.com
pharmiweb.com > press-release > 2026-05-14 > triple-hair-expands-global-phase-iii-program-for-th07-with-launch-of-500-patient-trial-in-india

Triple Hair Expands Global Phase III Program for TH07 with Launch of 500-Patient Trial in India

3+ mon, 4+ week ago   (315+ words) MONTRÉAL--(BUSINESS WIRE)--Triple Hair Group Inc. (“Triple Hair” or the “Company”), a company specializing in the development of innovative treatments for androgenic alopecia (pattern baldness), today announced the initiation of its Phase III clinical trial in India evaluating TH07, the…...

The Dermatology Digest
thedermdigest.com > expert-pearls-on-the-use-of-the-folix-laser-for-androgenetic-alopecia

Expert Pearls on the Use of the FoLix Laser for Androgenetic Alopecia

4+ mon, 1+ day ago   (113+ words) The Dermatology Digest Expert Pearls on the Use of the FoLix Laser for Androgenetic Alopecia With Dr. Jennifer Krejci Jennifer Krejci, MD, a Dermatologist at the Limmer Hair Transplant Center in San Antonio, TX, recently presented new data on FoLix…...

Medical Dialogues
medicaldialogues.in > dermatology > news > baricitinib-effective-and-safe-for-severe-alopecia-areata-when-started-early-study-169959

Baricitinib Effective and Safe for Severe Alopecia Areata when Started Early: Study

4+ mon, 4+ day ago   (152+ words) Spain: Researchers have found in a real-world prospective study of adults with severe Alopecia Areata that treatment with Baricitinib demonstrated good efficacy and safety over 12 months, particularly when initiated early. In the study, a clinically meaningful response was observed in…...

Google News
cyprus-mail.com

Hair growth treatments review: What actually works in 2026 (science-based guide)

4+ mon, 5+ day ago   (485+ words) Most people dealing with hair loss spend months trying different shampoos, oils, and supplements before realizing none of it is actually working. That’s not a personal failure — it’s a system problem. Hair loss is rarely one thing, and most treatments…...

The Chosun Daily
chosun.com > english > kpop-culture-en > 05/05/2026 > KNJNN572SBEHZOK2A3KYQQVYIU

Hair Loss: Early Treatment Before Follicles Close Permanently

4+ mon, 1+ week ago   (220+ words) New JAK Inhibitors Reduce Side Effects, Experts Stress Immediate Action to Prevent Irreversible Damage [OSEN=Kang Seo-jung Reporter] If hair falls out every time you wash or brush your hair, and the number keeps increasing, hair loss may have already…...

Yahoo Finance
finance.yahoo.com > sectors > healthcare > articles > veradermics-mane-reports-positive-phase-135751058.html

Veradermics (MANE) Reports Positive Phase 2/3 Results for Male Pattern Hair Loss Treatment VDPHL01

4+ mon, 1+ week ago   (321+ words) Yahoo Finance Oops, something went wrong U.S. markets open in 2h 41m Veradermics (MANE) Reports Positive Phase 2/3 Results for Male Pattern Hair Loss Treatment VDPHL01 Veradermics Incorporated (NYSE:MANE) is one of the small-cap stocks that are on fire right now. On April 27, Veradermics…...

Men's Health
menshealth.com > grooming > a70/83/6527 > new-hair-loss-treatments-pp405-minoxidil

Early Studies Show These New Hair Loss Treatments May Be More Effective Than Current Meds

5+ mon, 1+ week ago   (342+ words) At the American Academy of Dermatology’s annual conference, these experimental treatments stole the show. HAIR LOSS: CONFIDENCE-killing, difficult to treat, ubiquitous. In fact, the most common form of shedding—male androgenic alopecia (also known as male pattern hair loss)—is…...

Yahoo News
yahoo.com > news > articles > scientists-create-next-generation-hair-115100701.html

Scientists create next-generation hair loss treatment safe for both men and women

5+ mon, 2+ week ago   (1168+ words) A little change in the cycle that produces hair could tip the scales toward either healthy, continued hair growth or slow, progressive hair reduction. Many individuals suffering from hair loss have hair follicles that become “stuck” in their resting phase…...